Table 2.
Unadjusted | Adjusted | |||
---|---|---|---|---|
Characteristic | TR | 95% CI | TR | 95% CI |
Calendar year of HAART eligibility | ||||
1996–1998 | 1 | 1 | ||
1999–2002 | 1.18 | 1.04 – 1.32 | 1.08 | 0.95 – 1.24 |
2003–2007 | 1.02 | 0.79 – 1.31 | 0.97 | 0.71 – 1.31 |
Age (per 10 years) | 0.82 | 0.62 – 1.08 | ||
Female gender | 1.01 | 0.90 – 1.14 | ||
African American | 0.98 | 0.73 – 1.31 | ||
≥High school education | 0.94 | 0.86 – 1.04 | ||
Annual income <$5000† | 1.16 | 0.99 – 1.34 | ||
Employed† | 1.00 | 0.87 – 1.16 | ||
Homeless† | 1.19 | 1.01 – 1.41 | ||
Incarcerated† | 1.23 | 1.04 – 1.45 | ||
Any alcohol use† | 1.17 | 0.98 – 1.38 | ||
Injection drug use† | ||||
None | 1 | 1 | ||
<Daily | 1.15 | 0.94 – 1.40 | 1.04 | 0.95–1.15 |
≥ Daily | 1.61 | 1.01 – 2.55 | 1.29 | 1.02–1.62 |
Any non-injection drug use† | 1.20 | 0.99 – 1.46 | ||
Type of drug injected† | 1 | |||
None | 1.29 | 0.99 – 1.67 | ||
Cocaine alone | 1.05 | 0.82 – 1.35 | ||
Heroin alone | 1.26 | 1.02 – 1.57 | ||
Cocaine and Heroin | ||||
Any cocaine use† | 1.21 | 1.02 – 1.45 | ||
Crack use† | 1.09 | 0.94 – 1.27 | ||
Methadone maintenance† | 0.77 | 0.60 – 0.98 | ||
≥ 2 HIV-related symptoms‡ | 0.79 | 0.65 – 0.96 | ||
CD4 cell count (per 100 cell decrease)‡ | 0.93 | 0.87 – 0.98 | 0.94 | 0.88 – 0.99 |
Prior AIDS diagnosis | 0.62 | 0.41 – 0.94 | 0.75 | 0.56 – 0.96 |
Prior ART | 0.84 | 0.75 – 0.94 | ||
Usual source of care† | 0.60 | 0.40 – 0.89 | 0.74 | 0.58 – 0.96 |
Health insurance† | 0.68 | 0.53 – 0.88 | 0.80 | 0.66 – 0.97 |
Recruitment cohort | ||||
1988–89 | 1 | |||
1994–95 | 1.16 | 0.97 – 1.38 | ||
1998 | 0.90 | 0.71 – 1.13 |
Estimates are from lognormal survival models and reflect relative increases (TR >1.0) or decreases (TR <1.0) in time to HAART initiation; TR, time ratio; CI, confidence interval
Reflects characteristics/behaviors in the prior six months
CD4 cell count was lagged one visit